Identification of tumor-associated markers for diagnosis and therapy

Details for Australian Patent Application No. 2008315929 (hide)

Owner Ganymed Pharmaceuticals AG Johannes Gutenberg-Universitat Mainz

Inventors Tureci, Ozlem; Koslowski, Michael; Sahin, Ugur

Agent Spruson & Ferguson

Pub. Number AU-A-2008315929

PCT Pub. Number WO2009/053041

Priority EP07020730.3 23.10.07 EP

Filing date 22 October 2008

Wipo publication date 30 April 2009

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/053041 Priority application(s): WO2009/053041

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008315931-Herbicide-safener combination

2008315926-Combination therapy of a type II antiCD20 antibody with a proteasome inhibitor